BUONTEMPO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.534
EU - Europa 1.655
AS - Asia 1.605
AF - Africa 135
SA - Sud America 75
OC - Oceania 3
Totale 6.007
Nazione #
US - Stati Uniti d'America 2.521
SG - Singapore 486
CN - Cina 458
GB - Regno Unito 426
VN - Vietnam 339
IT - Italia 283
SE - Svezia 269
DE - Germania 216
HK - Hong Kong 120
RU - Federazione Russa 91
IN - India 89
FR - Francia 73
IE - Irlanda 65
ZA - Sudafrica 48
UA - Ucraina 47
BR - Brasile 45
TG - Togo 38
EE - Estonia 34
JO - Giordania 31
NL - Olanda 30
CH - Svizzera 21
CI - Costa d'Avorio 21
AT - Austria 20
IR - Iran 20
BG - Bulgaria 17
JP - Giappone 16
KR - Corea 16
BE - Belgio 15
FI - Finlandia 13
AR - Argentina 12
CL - Cile 11
SC - Seychelles 11
CA - Canada 8
PL - Polonia 8
ID - Indonesia 6
NG - Nigeria 6
PT - Portogallo 5
RO - Romania 5
CZ - Repubblica Ceca 4
ES - Italia 4
LB - Libano 4
BD - Bangladesh 3
DZ - Algeria 3
MX - Messico 3
TR - Turchia 3
UZ - Uzbekistan 3
AU - Australia 2
CO - Colombia 2
EC - Ecuador 2
EG - Egitto 2
GR - Grecia 2
MY - Malesia 2
PK - Pakistan 2
AZ - Azerbaigian 1
BF - Burkina Faso 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
GM - Gambi 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
VE - Venezuela 1
ZM - Zambia 1
Totale 6.007
Città #
Southend 375
Singapore 312
Ashburn 304
Fairfield 267
Chandler 180
Dong Ket 173
Houston 166
Woodbridge 150
Wilmington 138
Bologna 130
Seattle 127
Hong Kong 120
Santa Clara 110
Ann Arbor 105
Cambridge 88
Princeton 79
Dublin 65
Beijing 61
Boardman 55
Dallas 47
Hefei 45
New York 44
Nanjing 40
Westminster 40
Lomé 38
Padova 35
Los Angeles 34
Amman 31
Ho Chi Minh City 24
Berlin 23
Abidjan 21
Bremen 21
Jinan 21
Shenyang 21
Bern 20
Frankfurt am Main 20
Hanoi 19
Jacksonville 19
Changsha 18
Saint Petersburg 18
Redondo Beach 17
Sofia 17
Brussels 14
Seoul 14
Turin 14
Vienna 14
Falls Church 13
Nanchang 13
Tokyo 13
Florence 11
Zhengzhou 11
Guangzhou 10
Haikou 10
Hangzhou 10
Helsinki 10
Medford 10
Norwalk 10
Redmond 10
San Diego 10
Buffalo 9
Hebei 9
London 9
Rome 8
Tianjin 8
Dearborn 7
Johannesburg 7
Munich 7
Mülheim 7
Pune 7
Abeokuta 6
Chicago 6
Falkenstein 6
Fuzhou 6
Jiaxing 6
Lauterbourg 6
Ningbo 6
San Francisco 6
Shanghai 6
Washington 6
Amsterdam 5
Bengaluru 5
Ninh Bình 5
Nuremberg 5
Redwood City 5
Toronto 5
Andover 4
Clearwater 4
Düsseldorf 4
Hải Dương 4
Jakarta 4
Kuban 4
Olalla 4
Phoenix 4
Plauen 4
Portsmouth 4
Szczypiorno 4
São Paulo 4
Yubileyny 4
Zanjan 4
Bühl 3
Totale 4.062
Nome #
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 248
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 223
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 209
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device 208
Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells. 194
Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device 192
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line 191
Therapeutic targeting of CK2 in acute and chronic leukemias. 184
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 181
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 180
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 177
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 170
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 166
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 161
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 159
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 155
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 155
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. 151
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 150
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 148
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 147
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 143
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 143
Compact and very high dose-rate plasma focus radiation sources for medical applications 140
Nuclear phosphoinositides and their roles in cell biology and disease. 135
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 135
Protective effect of different antioxidant agents in UVB-irradiated keratinocytes 134
Drug discovery targeting the mTOR pathway 130
Diet modulation restores autophagic flux in damaged skeletal muscle cells. 121
GSK-3β: a key regulator of breast cancer drug resistance 119
Marine bisindole alkaloid: a potential apoptotic inducer in cancer cells. 118
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 117
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. 107
Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications 104
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 101
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status 98
null 95
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells 91
EVALUATION OF THE EFFICACY AND ANTITUMOR ACTIVITY OF THE PAN-CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITOR NVP-BKM120 IN HUMAN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) 85
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 81
INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY? 71
HNE protein adducts and apoptosis in osteosarcoma cells 47
null 43
Tyrosol prevents apoptosis in irradiated keratinocytes. 37
Totale 6.144
Categoria #
all - tutte 16.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021436 0 0 0 0 0 15 15 27 58 24 31 266
2021/2022947 148 19 61 59 78 48 19 61 33 126 180 115
2022/2023855 78 119 48 131 55 61 29 42 166 9 71 46
2023/2024261 18 34 25 25 26 89 5 9 7 11 7 5
2024/2025801 15 111 81 63 177 42 56 27 1 58 33 137
2025/2026984 183 149 190 124 250 88 0 0 0 0 0 0
Totale 6.144